Novartis explains stance over India patent law challenge

Article Date: 27/02/2012 08:00
Novartis explains stance over India patent law challenge

Vacancy Search

Quick job search

Advanced Search

Latest News

GAVI pledges top $7.5 billion as Gates defends pharma

GAVI pledges top $7.5 billion as Gates defends pharma

Final NICE yes for £58m a year Soliris

Final NICE yes for £58m a year Soliris

Pfizer under no pressure to do M&A but earnings fall

Pfizer under no pressure to do M&A but earnings fall

Biogen and Google ink MS pact: Bloomberg report

Biogen and Google ink MS pact: Bloomberg report

AZ launches Bydureon pre-filled injector pen in UK

AZ launches Bydureon pre-filled injector pen in UK

Labour gears up for election with NHS pledges

Labour gears up for election with NHS pledges

Common drugs linked to dementia risk in elderly

Common drugs linked to dementia risk in elderly

UK stuck in middle of Europe healthcare ranking

UK stuck in middle of Europe healthcare ranking

Novartis earnings fall as group sets up for future growth

Novartis earnings fall as group sets up for future growth

Teva gets OK for first US generic of AZ's Nexium

Teva gets OK for first US generic of AZ's Nexium
more news